Patent application number | Description | Published |
20080208418 | Motor-Driven Vehicle with Transmission - A motor-driven vehicle includes at least an engine, control devices arranged to control a transmission driven by the engine, a first sensor that is arranged to communicate with the control devices, and a second sensor that is arranged to communicate with the control devices, with the control devices being arranged to receive a first signal sent from the first sensor that includes information about the gradient of the surface on which the vehicle is being driven, and with the control devices being arranged to receive a second signal sent from the second sensor that includes information about torque. The control devices are arranged to correct the first signal in response to the second signal, and to control the transmission in response to the corrected first signal, and thereby compensate for the effect of the torque on the first sensor. | 08-28-2008 |
20080234905 | Method for Identifying a Road Condition During Driving of a Vehicle - A method for identifying a road condition during driving of a vehicle. The vehicle includes an engine with an engine output shaft connected to an automated mechanical transmission via a clutch. A transmission output shaft is connected to at least one driven wheel of the vehicle, and the system further includes a vehicle suspension system with sensors for measuring the vertical movement of wheels of the vehicle relative vehicle bodywork, at least one control unit adapted to receive a variety of input signals and process those signals in accordance with programmed logic rules to issue command output signals to the engine, for torque request, to the transmission for gear shifting and to the clutch. The control unit, when sensing driving conditions, sends signals indicative of a first road condition and is programmed to change gear shifting strategy for the transmission to a gear shifting strategy optimized for the first road condition if present gear shifting strategy is a second gear shifting strategy for a second road condition. One of the road conditions can be off-road. | 09-25-2008 |
20100313551 | METHOD AND SYSTEM FOR REGENERATING AN EXHAUST GAS PURIFICATION UNIT - A method for regenerating an exhaust gas purification unit arranged in an internal combustion engine system includes setting a predefined minimum engine speed such that the exhaust gas mass flow exceeds a predefined flow value during the regeneration process. An internal combustion engine system including an exhaust gas purification unit adapted to be operated according to the method is also provided. | 12-16-2010 |
20110054748 | ENGINE DRIVEN VEHICLE WITH TRANSMISSION - An engine driven vehicle includes at least one engine, and control devices that are arranged to control a transmission that is driven by the engine. The control devices are arranged to receive at least two sets of data, each set comprising at least one of a first signal that comprises information about the gradient of the surface on which the vehicle is being driven sent from a first sensor, and at least one second signal that comprises information about the vehicle's speed sent from a second sensor, and at least one third signal that comprises information about the vehicle's acceleration. The invention is characterized in that the control devices are also arranged to calculate at least one of two different resistance to travel constants k | 03-03-2011 |
20140149006 | METHOD TO CONTROL A DRIVETRAIN OF A VEHICLE - A method is provided to control a drivetrain of a vehicle, especially a utility vehicle, wherein the drivetrain includes an engine with a cooling system. The cooling system includes a fan. The cooling system and the drivetrain are controlled by an electronic control unit (ECU). The ECU has access to a navigation system with topographic data. The method includes determining a topology of an upcoming route of the vehicle, estimating the load of the engine dependent of the topology of the upcoming route, estimating a temperature variation of the cooling system during the upcoming route, and controlling the drivetrain dependent on the estimated temperature variation, such that an actual temperature of the cooling system is kept below a temperature threshold value during the upcoming route of the vehicle. The temperature threshold value is dependent on a temperature at which said fan is activated. | 05-29-2014 |
Patent application number | Description | Published |
20100326443 | METHOD AND DEVICE FOR GAS SUPPLY DURING CARDIOPULMONARY RESUSCITATION - A method and device for providing ventillation gas to a patient during cardiopulmonary resuscitation, mechanically or manually. The includes comprises: a gas source, a tracheal tube arranged in the trachea of a patient, a gas channel in the tracheal tube, for supplying gas, such as oxygen, to the bronchi of the patient, a central channel for connecting the bronchi to the atmosphere, a flow valve for adjusting the flow rate of the gas supplied, and a switch valve for initiating and terminating the gas supply. The device is operated by a computer to cycle the patient through a series of operational phases. | 12-30-2010 |
20110003275 | SYSTEM AND METHOD FOR ORGAN EVALUATION AND PRESERVATION - A method and system for organ evaluation and preservation for connection to an organ and for recirculation of a perfusion medium there through. The system comprises a first collection device for collection of the perfusion medium perfused through the organ and a second collection device arranged in an outlet conduit from the first collection device. A pump passes the perfusion medium from the second collection device to the organ via a conduit. A flow regulation device, such as an on-off clamp, is arranged in the outlet conduit for controlling the flow in the outlet conduit in order to maintain a constant fill of the second collection device as measured by a fluid level sensing device. | 01-06-2011 |
20110065169 | APPARATUS FOR HOUSING AN ORGAN DURING EVALUATION AND PRESERVATION - A vessel for housing an organ such as lungs from a mammal ex-vivo, for evaluation or preservation. A liquid solution suitable for evaluation or preservation of the lungs surrounds the organ, at least partly. The solution is circulated via an outlet and an inlet. Two pressure chambers are arranged between the walls of the vessel and the organ. A gas is introducible to the pressure chamber in order to expand the pressure chamber for occupying the spaces surrounding the organ. Then, the pressure inside the pressure chambers is increased in order to push the solution to a higher level so that the organ is immersed in the solution without necessitating addition of further solution. Alternatively, the vessel is exposed to an under pressure and the pressure chambers are open to the atmosphere. In a further alternative embodiment, a solution collection space has variable volume. | 03-17-2011 |
20110144006 | PROTEIN COMPOSITION - The invention relates to a protein composition which upon ingestion by a healthy person with a normal fasting insulin level between 3.0-8.0 μU/L increases the insulin level to at most 20.0 μU/L. The invention may be in the shape of a powder, capsules, pellets, tablets, effervescent tablets or food products comprising said protein composition. | 06-16-2011 |
20110269112 | EVALUATION AND PRESERVATION SOLUTION - An evaluation and preservation solution for human and animal organs, tissues and parts thereof is described, wherein it comprises serum albumin at a concentration of 55-105 g/L, a scavenger and coating compound, preferably dextran compounds and derivatives thereof having essentially the same structure at a concentration of 1-55 g/L weight, and a physiological serum concentration of salts and nutrients in a physiologically acceptable medium. | 11-03-2011 |
20110270215 | COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR - A composition, an infusion solution, a method for treatment, and a kit for intravascular administration for treatment of a brain-dead, heart-beating, respirated, potential organ donor. The composition has a non-adrenaline and NET inhibitor for noradrenaline. The NET inhibitor may be cocaine or an analogue thereof or a tricyclic antidepressant. The composition may in addition include adrenaline, hydrocortisone, thyroxin, insulin, triiodotyronine, dopamine, a vasopressor agent, such as desmopressin, and methylprednisolone. The ratio between the NET inhibitor and nor-adrenaline is about 1:1. The composition may be dissolved in pure water, Ringer's acetate solution or physiological sodium chloride solution. The composition is infused in such an amount as to maintain a mean arterial pressure of about 60 mmHg. The composition may be infused by a pump at a rate of about 1.7 ml/hour decreasing dose-dependent to about 0.4 ml/hour after 24 hours. | 11-03-2011 |
20110305798 | NUTRITIONAL SUPPLEMENT WITH SPECIFIC AMINO ACID PROFILE - The invention relates to a powder, such as an amino acid and/or protein powder that is optimized for human beings in the respect that its combined amino acid profile reflects the amino acid profile of human mother's milk protein. The invented powder, such as an amino acid and/or protein powder is suitable to be used as a nutrition supplement and relates also to tablets, capsules or pellets comprising said protein mixture, as well as food products comprising said protein mixture. | 12-15-2011 |
20120183945 | METHOD, DEVICE AND FLUID FOR TREATMENT OF A HEART AFTER HARVESTING - Method and device for treatment of a heart after harvesting and before transplantation. The device includes a container intended to comprise the heart; a first line for connection to an aorta of the heart; a fluid circuit comprising an oxygenator for oxygenating said fluid and a heater/cooler for regulating the temperature of said fluid; and a pump for perfusion of said fluid through the coronary blood vessels of the heart. The fluid includes an oncotic agent exerting an oncotic pressure larger than about 30 mmHg; and is cardioplegic by comprising a potassium concentration, which is between 15 mM and 30 mM. A control device is arranged for controlling the pump to perform said perfusion intermittently, whereby the perfusion time is less than half of the cycle time. The perfusion is performed at a pressure, which is at least 15 mmHg and at least 15 mmHg lower than said oncotic pressure. | 07-19-2012 |
20120184024 | Container and Supporting Structure for Housing an Organ - An apparatus intended for evaluation, preservation and perfusion of an organ, such as a lung. The apparatus includes a container with a bottom portion, an insert portion and a lid portion. A pulmonary artery tube is intended to be connected to the lung pulmonary artery and a trachea tube is intended to be connected to the trachea of the lungs and bent tube connects the pulmonary artery tube to a circuit for providing a fluid to the pulmonary artery is provided. The circuit includes a pump, an oxygenator, an optional leukocyte-filter, and a holder for connecting the trachea tube to a source of respiration. There is an oxygenator tube set and a leukocyte-filter tube set. A supporting structure for the container comprises a recess sized for enclosing said container and a display panel. Moreover, there are two handles, which may be unfolded into a position for supporting a sterile cloth. | 07-19-2012 |
20130065218 | MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID - A medical fluid for a harvested organ, tissue or parts thereof, for evaluation and/or preservation. The fluid includes cocaine or a stimulating analogue thereof; nor-adrenalin; and/or adrenaline. In addition, the fluid includes an oncotic agent, such as dextran; hormones, such as thyroxin; triiodotyronine; cortisone, insulin; and electrolytes and optionally nutrients in substantially physiological concentrations in a physiologically acceptable medium. In addition, the medical fluid further includes albumin in a concentration not exceeding 5.0%, and an oxygen carrier, such as erythrocytes. Further components may be dopamine; hydrocortisone; methylprednisolone; and a vasopressor agent, such as desmopressin. The cocaine; adrenalin; and noradrenaline are present in concentrations of each about 0.010 μM to 0.100 μM, for example in a ratio of 1:1:1. | 03-14-2013 |
20140007961 | APPARATUS FOR MAINTAINING A HARVESTED ORGAN VIABLE AND TRANSPORTABLE - An apparatus for enclosing an organ after harvesting and before implantation, having; a vessel enclosing a fluid, a connection tube for connecting a circulation hose to the organ for passing a fluid to the organ by a pump, and a degassing hose extending from the connection tube to the vessel. A pinch valve is arranged in the degassing hose. During a degassing phase, the pinch valve is opened to allow fluid flow from the pump, via the circulation hose to the connection tube and via the degassing hose to the vessel for expelling air entrapped in the fluid flow system. A balloon is arranged to prevent fluid flow via the connection tube to the organ during the degassing phase. A sterility arrangement closes the vessel at the top and may be replaced by further sterility arrangements without compromising the sterility. | 01-09-2014 |
20140255905 | MEDICAL FLUID COMPRISING GLOBULIN AND ITS USE FOR PRESERVATION OF HARVESTED ORGANS - A medical fluid for a harvested organ, tissue or parts thereof, for evaluation and/or preservation. The fluid comprise oncotic agents, comprising albumin, a dextran compound and at least one globulin. The globulin has a concentration, which is larger than physiological concentration thereof. In addition, the fluid comprises hormones, such as thyroxin; triiodotyronine; cortisone, insulin; and electrolytes and optionally nutrients in substantially physiological concentrations in a physiologically acceptable medium. Moreover, the medical fluid comprises an oxygen carrier, such as erythrocytes. Further components may be dopamine; hydrocortisone; methylprednisolone; and a vasopressor agent, such as desmopressin. Moreover, cocaine, adrenalin, and/or noradrenalin, may be present in concentrations of each about 1 nM to 100 nM, for example in a ratio of 1:1:1. | 09-11-2014 |